Calcium in PDB 5hpw: Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination
Protein crystallography data
The structure of Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination, PDB code: 5hpw
was solved by
R.P.Singh,
A.Singh,
P.Sharma,
P.Kaur,
S.Sharma,
T.P.Singh,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
42.50 /
2.50
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
80.221,
82.588,
95.083,
80.91,
73.71,
89.96
|
R / Rfree (%)
|
26 /
31.1
|
Other elements in 5hpw:
The structure of Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination
(pdb code 5hpw). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 4 binding sites of Calcium where determined in the
Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination, PDB code: 5hpw:
Jump to Calcium binding site number:
1;
2;
3;
4;
Calcium binding site 1 out
of 4 in 5hpw
Go back to
Calcium Binding Sites List in 5hpw
Calcium binding site 1 out
of 4 in the Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca605
b:43.0
occ:1.00
|
O
|
A:THR184
|
2.3
|
28.0
|
1.0
|
OD1
|
A:ASP110
|
2.6
|
29.2
|
1.0
|
OG1
|
A:THR184
|
2.6
|
30.7
|
1.0
|
O
|
A:PHE186
|
2.6
|
36.0
|
1.0
|
OG
|
A:SER190
|
2.6
|
34.7
|
1.0
|
O
|
A:ASP110
|
2.7
|
34.7
|
1.0
|
OD1
|
A:ASP188
|
2.9
|
22.2
|
1.0
|
C
|
A:THR184
|
3.2
|
32.0
|
1.0
|
CB
|
A:SER190
|
3.4
|
31.4
|
1.0
|
CG
|
A:ASP188
|
3.5
|
21.1
|
1.0
|
C
|
A:ASP110
|
3.6
|
28.0
|
1.0
|
OD2
|
A:ASP188
|
3.6
|
18.0
|
1.0
|
CB
|
A:THR184
|
3.7
|
37.3
|
1.0
|
CA
|
A:THR184
|
3.7
|
32.1
|
1.0
|
N
|
A:THR184
|
3.7
|
26.9
|
1.0
|
CG
|
A:ASP110
|
3.8
|
32.2
|
1.0
|
C
|
A:PHE186
|
3.8
|
27.3
|
1.0
|
N
|
A:ASP188
|
4.1
|
34.4
|
1.0
|
N
|
A:SER190
|
4.2
|
32.7
|
1.0
|
N
|
A:PHE186
|
4.3
|
29.3
|
1.0
|
CA
|
A:ASP110
|
4.3
|
23.5
|
1.0
|
CA
|
A:SER190
|
4.3
|
36.0
|
1.0
|
N
|
A:SER185
|
4.4
|
32.2
|
1.0
|
O
|
A:HOH716
|
4.4
|
18.6
|
1.0
|
C
|
A:SER185
|
4.5
|
32.7
|
1.0
|
N
|
A:LEU111
|
4.5
|
25.8
|
1.0
|
CB
|
A:ASP110
|
4.6
|
27.3
|
1.0
|
CA
|
A:PHE186
|
4.6
|
29.2
|
1.0
|
CA
|
A:LEU111
|
4.6
|
24.1
|
1.0
|
OD2
|
A:ASP110
|
4.6
|
30.5
|
1.0
|
CB
|
A:ASP188
|
4.7
|
25.3
|
1.0
|
CG2
|
A:THR184
|
4.8
|
36.8
|
1.0
|
N
|
A:LEU187
|
4.8
|
32.0
|
1.0
|
CA
|
A:ASP188
|
4.8
|
30.4
|
1.0
|
CA
|
A:SER185
|
4.9
|
28.1
|
1.0
|
O
|
A:SER185
|
4.9
|
37.6
|
1.0
|
CA
|
A:LEU187
|
4.9
|
30.6
|
1.0
|
CB
|
A:VAL183
|
4.9
|
25.1
|
1.0
|
C
|
A:VAL183
|
4.9
|
29.6
|
1.0
|
CG2
|
A:VAL183
|
4.9
|
28.3
|
1.0
|
C
|
A:ASP188
|
5.0
|
27.3
|
1.0
|
|
Calcium binding site 2 out
of 4 in 5hpw
Go back to
Calcium Binding Sites List in 5hpw
Calcium binding site 2 out
of 4 in the Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca604
b:44.9
occ:1.00
|
O
|
B:ASP110
|
2.5
|
41.1
|
1.0
|
O
|
B:THR184
|
2.6
|
29.8
|
1.0
|
O
|
B:PHE186
|
2.6
|
39.7
|
1.0
|
OG1
|
B:THR184
|
2.6
|
36.8
|
1.0
|
OD1
|
B:ASP110
|
2.6
|
35.8
|
1.0
|
OD1
|
B:ASP188
|
2.8
|
22.5
|
1.0
|
OG
|
B:SER190
|
3.0
|
47.1
|
1.0
|
C
|
B:ASP110
|
3.2
|
33.8
|
1.0
|
C
|
B:THR184
|
3.4
|
32.0
|
1.0
|
CG
|
B:ASP110
|
3.7
|
39.8
|
1.0
|
C
|
B:PHE186
|
3.7
|
35.8
|
1.0
|
CG
|
B:ASP188
|
3.8
|
37.8
|
1.0
|
CB
|
B:SER190
|
3.8
|
52.7
|
1.0
|
CB
|
B:THR184
|
3.8
|
34.7
|
1.0
|
N
|
B:THR184
|
3.8
|
33.4
|
1.0
|
CA
|
B:THR184
|
3.9
|
34.2
|
1.0
|
CA
|
B:ASP110
|
3.9
|
30.1
|
1.0
|
N
|
B:LEU111
|
4.0
|
32.9
|
1.0
|
OD2
|
B:ASP188
|
4.1
|
48.5
|
1.0
|
CB
|
B:ASP110
|
4.2
|
32.2
|
1.0
|
N
|
B:PHE186
|
4.2
|
35.9
|
1.0
|
N
|
B:ASP188
|
4.2
|
40.5
|
1.0
|
N
|
B:SER190
|
4.3
|
54.4
|
1.0
|
CA
|
B:LEU111
|
4.3
|
31.9
|
1.0
|
O
|
B:HOH725
|
4.5
|
8.4
|
1.0
|
N
|
B:SER185
|
4.5
|
31.6
|
1.0
|
CA
|
B:PHE186
|
4.6
|
34.9
|
1.0
|
N
|
B:LEU187
|
4.6
|
33.6
|
1.0
|
CA
|
B:LEU187
|
4.6
|
34.7
|
1.0
|
CB
|
B:VAL183
|
4.6
|
34.6
|
1.0
|
C
|
B:SER185
|
4.6
|
37.2
|
1.0
|
CA
|
B:SER190
|
4.6
|
53.4
|
1.0
|
CG2
|
B:THR184
|
4.7
|
33.6
|
1.0
|
CG2
|
B:VAL183
|
4.8
|
41.3
|
1.0
|
OD2
|
B:ASP110
|
4.8
|
33.4
|
1.0
|
C
|
B:VAL183
|
4.8
|
33.6
|
1.0
|
N
|
B:ALA189
|
4.8
|
54.3
|
1.0
|
CA
|
B:SER185
|
4.9
|
32.0
|
1.0
|
C
|
B:LEU187
|
4.9
|
37.0
|
1.0
|
C
|
B:LEU111
|
5.0
|
38.8
|
1.0
|
O
|
B:LEU111
|
5.0
|
39.2
|
1.0
|
|
Calcium binding site 3 out
of 4 in 5hpw
Go back to
Calcium Binding Sites List in 5hpw
Calcium binding site 3 out
of 4 in the Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Ca605
b:46.5
occ:1.00
|
O
|
C:PHE186
|
2.4
|
31.8
|
1.0
|
OD1
|
C:ASP110
|
2.6
|
43.8
|
1.0
|
O
|
C:THR184
|
2.7
|
37.2
|
1.0
|
O
|
C:ASP110
|
2.7
|
31.0
|
1.0
|
OD1
|
C:ASP188
|
2.7
|
34.2
|
1.0
|
OG1
|
C:THR184
|
2.8
|
30.3
|
1.0
|
OG
|
C:SER190
|
2.9
|
50.7
|
1.0
|
C
|
C:ASP110
|
3.2
|
30.9
|
1.0
|
C
|
C:PHE186
|
3.4
|
39.7
|
1.0
|
C
|
C:THR184
|
3.5
|
36.1
|
1.0
|
CG
|
C:ASP110
|
3.5
|
38.6
|
1.0
|
CG
|
C:ASP188
|
3.6
|
33.3
|
1.0
|
CB
|
C:SER190
|
3.6
|
42.9
|
1.0
|
N
|
C:ASP188
|
3.8
|
34.1
|
1.0
|
N
|
C:LEU111
|
3.9
|
31.9
|
1.0
|
CA
|
C:ASP110
|
3.9
|
30.5
|
1.0
|
N
|
C:PHE186
|
3.9
|
38.2
|
1.0
|
CB
|
C:THR184
|
4.0
|
34.7
|
1.0
|
CA
|
C:LEU111
|
4.1
|
28.6
|
1.0
|
CA
|
C:THR184
|
4.2
|
37.0
|
1.0
|
N
|
C:LEU187
|
4.2
|
37.9
|
1.0
|
C
|
C:SER185
|
4.2
|
38.4
|
1.0
|
OD2
|
C:ASP188
|
4.2
|
39.8
|
1.0
|
CB
|
C:ASP110
|
4.2
|
33.0
|
1.0
|
CA
|
C:LEU187
|
4.2
|
36.7
|
1.0
|
N
|
C:THR184
|
4.3
|
33.3
|
1.0
|
N
|
C:SER185
|
4.3
|
32.9
|
1.0
|
CA
|
C:PHE186
|
4.3
|
38.4
|
1.0
|
OD2
|
C:ASP110
|
4.3
|
42.4
|
1.0
|
CA
|
C:SER185
|
4.5
|
39.4
|
1.0
|
CB
|
C:ASP188
|
4.5
|
36.0
|
1.0
|
O
|
C:LEU111
|
4.5
|
37.9
|
1.0
|
N
|
C:SER190
|
4.5
|
41.8
|
1.0
|
C
|
C:LEU187
|
4.6
|
36.4
|
1.0
|
O
|
C:SER185
|
4.6
|
34.0
|
1.0
|
O
|
C:HOH702
|
4.6
|
7.2
|
1.0
|
C
|
C:LEU111
|
4.7
|
33.0
|
1.0
|
CA
|
C:SER190
|
4.7
|
39.9
|
1.0
|
CA
|
C:ASP188
|
4.7
|
37.6
|
1.0
|
CG2
|
C:VAL183
|
4.8
|
34.8
|
1.0
|
|
Calcium binding site 4 out
of 4 in 5hpw
Go back to
Calcium Binding Sites List in 5hpw
Calcium binding site 4 out
of 4 in the Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Ca605
b:36.3
occ:1.00
|
O
|
D:THR184
|
2.4
|
31.9
|
1.0
|
OD1
|
D:ASP110
|
2.5
|
33.9
|
1.0
|
O
|
D:PHE186
|
2.6
|
23.3
|
1.0
|
OG1
|
D:THR184
|
2.6
|
46.1
|
1.0
|
OG
|
D:SER190
|
2.7
|
40.7
|
1.0
|
O
|
D:ASP110
|
2.8
|
34.1
|
1.0
|
OD1
|
D:ASP188
|
2.9
|
26.0
|
1.0
|
C
|
D:THR184
|
3.0
|
33.5
|
1.0
|
CB
|
D:THR184
|
3.2
|
35.8
|
1.0
|
C
|
D:ASP110
|
3.4
|
29.1
|
1.0
|
CA
|
D:THR184
|
3.4
|
33.8
|
1.0
|
CG
|
D:ASP188
|
3.5
|
26.7
|
1.0
|
C
|
D:PHE186
|
3.5
|
21.2
|
1.0
|
CG
|
D:ASP110
|
3.6
|
29.5
|
1.0
|
CB
|
D:SER190
|
3.6
|
40.6
|
1.0
|
OD2
|
D:ASP188
|
3.7
|
32.2
|
1.0
|
N
|
D:THR184
|
3.8
|
24.9
|
1.0
|
N
|
D:PHE186
|
3.8
|
32.5
|
1.0
|
N
|
D:SER185
|
3.9
|
33.5
|
1.0
|
N
|
D:ASP188
|
3.9
|
27.0
|
1.0
|
CA
|
D:ASP110
|
4.1
|
29.3
|
1.0
|
N
|
D:LEU111
|
4.2
|
32.3
|
1.0
|
C
|
D:SER185
|
4.2
|
30.1
|
1.0
|
CB
|
D:ASP110
|
4.3
|
31.2
|
1.0
|
CA
|
D:PHE186
|
4.3
|
25.6
|
1.0
|
CA
|
D:SER185
|
4.4
|
29.7
|
1.0
|
N
|
D:LEU187
|
4.5
|
27.5
|
1.0
|
CA
|
D:LEU187
|
4.5
|
29.9
|
1.0
|
CA
|
D:LEU111
|
4.5
|
21.6
|
1.0
|
OD2
|
D:ASP110
|
4.5
|
27.1
|
1.0
|
CB
|
D:ASP188
|
4.6
|
32.3
|
1.0
|
N
|
D:SER190
|
4.6
|
30.3
|
1.0
|
CG2
|
D:THR184
|
4.7
|
34.3
|
1.0
|
CA
|
D:SER190
|
4.7
|
33.7
|
1.0
|
CA
|
D:ASP188
|
4.7
|
33.2
|
1.0
|
C
|
D:VAL183
|
4.7
|
24.3
|
1.0
|
C
|
D:LEU187
|
4.8
|
27.5
|
1.0
|
O
|
D:HOH705
|
4.9
|
24.0
|
1.0
|
O
|
D:SER185
|
4.9
|
26.2
|
1.0
|
CB
|
D:PHE186
|
5.0
|
26.7
|
1.0
|
|
Reference:
R.P.Singh,
A.Singh,
P.Sharma,
P.Kaur,
S.Sharma,
T.P.Singh.
Mode of Binding of Antithyroid Drug, Propylthiouracil to Lactoperoxidase: Binding Studies and Structure Determination To Be Published.
Page generated: Sun Jul 14 20:09:49 2024
|